MAMBA FlexRecalls & reported problems across all models
Boston Scientific Corporation · 2 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls
- 1
We found 2 models of MAMBA Flex by Boston Scientific Corporation in the FDA's device registry (GUDID). Together they are named in 9 adverse event reports in the FDA's MAUDE database, received between Nov 2, 2020 and Sep 11, 2025 — classified as 1 injury, 8 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (6 reports).
1 FDA recall record name at least one of these models by its device identifier.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
MAMBA Flex recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Mar 5, 2021Terminated
The firm initiated a removal of certain batches of MAMBA 135 and MAMBA Flex 135 Microcatheters due to incorrect labeling and packaging.
Z-1429-2021 · Root cause: Labeling False and Misleading · Recall details · FDA record ↗
Most reported MAMBA Flex problems
Device problems
- Difficult to Remove6
- Physical Resistance/Sticking3
- Difficult to Flush2
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
- Device Contamination with Chemical or Other Material1
- Device-Device Incompatibility1
- Difficult to Advance1
Patient problems
- No Clinical Signs, Symptoms or Conditions7
- Insufficient Information1
- No Consequences Or Impact To Patient1
MAMBA Flex models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- MAMBA™ Flex H7493928713540CATHETER, PERCUTANEOUS1 recall7 reports
- MAMBA™ Flex H7493928715000CATHETER, PERCUTANEOUS2 reports
Recent MAMBA Flex adverse event reports
The 9 most recent reports across all models, in the reporter's own words as published by the FDA.
MalfunctionSep 11, 2025Difficult to Remove; Difficult to Remove
IT REPORTED THAT REMOVAL DIFFICULTIES OCCURRED. THE PATIENT WITH STABLE CORONARY ARTERY DISEASE (CAD) UNDERWENT PERCUTANEOUS CORONARY INTERVENTION (PCI). THE TARGET LESION WAS A CHRONIC TOTAL OCCLUSION (CTO) LOCATED IN THE CIRCUMFLEX ARTERY (CX), WHICH WAS MODERATELY TORTUOUS AND MILDLY CALCIFIED. A 135CM MAMBA FLEX MICROCATHETER WAS SELECTED FOR USE. A NON-BSC GUIDEWIRE WAS USED TO DELIVER THE MAMBA, THEN EXCHANGED FOR ANOTHER NON-BSC WIRE THAT SUCCESSFULLY CROSSED THE LESION. THE MAMBA WAS ADVANCED INTO THE DISTAL CX, AFTER WHICH THE SECOND WIRE WAS REMOVED, AND THE ORIGINAL GUIDEWIRE REINTRODUCED. DURING SUBSEQUENT REMOVAL OF THE MAMBA CATHETER, SIGNIFICANT RESISTANCE WAS ENCOUNTERED WHILE ATTEMPTING TO RETRACT THE NON-BSC GUIDEWIRE. THE NON-BSC GUIDEWIRE BECAME FROZEN IN THE MAMBA CATHETER. AFTER CONSIDERABLE EFFORT, THE WIRE WAS SUCCESSFULLY REMOVED. DESPITE INCREASING RESISTANCE DURING MAMBA CATHETER REMOVAL, THE NON-BSC GUIDEWIRE WAS WIPED DOWN MULTIPLE TIMES IN AN EFFORT TO FACILITATE RETRACTION. FORTUNATELY, THE MAMBA WAS SUCCESSFULLY REMOVED WITHOUT COMPLICATION AND THE PROCEDURE SUCCESSFULLY COMPLETED WITH OTHER DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23027422 ↗MalfunctionMar 6, 2024Difficult to Flush; Difficult to Remove; Difficult to Flush; Difficult to Remove
IT REPORTED THAT REMOVAL DIFFICULTIES OCCURRED. THE 70% STENOSED TARGET LESION WAS NONE TORTUOUS AND MODERATELY CALCIFIED LEFT ANTERIOR DESCENDING CORONARY ARTERY (LAD). A 135 CM MAMBA FLEX WAS USED AS AN EXCHANGE DEVICE DURING A ROTABLATION PROCEDURE. THE MAMBA WAS FLUSHED, AND THE NON-BOSTON SCIENTIFIC (BSC) WIRE WAS INSERTED INTO THE CATHETER. THE MAMBA AND NON-BSC WIRE DEVICES PLACED INTO THE GUIDE CATHETER AT THE SAME TIME AND ADVANCED TO THE LESION WITH THE NON-BS WIRE LEADING ACROSS THE CALCIFIED LESION. THEN, THE NON-BSC WIRE WAS REMOVED, AND THE ROTOWIRE DRIVE WAS ADVANCED IN LESION. ONCE THE ROTOWIRE DRIVE WAS AT DISTAL TO THE LESION, THE MAMBA WAS REMOVED. THE ROTABLATION SUCCESSFULLY COMPLETED AND THE ROTAPRO WAS REMOVED OVER THE ROTAWIRE. THEN, THE MAMBA ADVANCED INTO THE DISTAL LAD OVER THE ROTAWIRE. UPON REMOVAL, THE ROTAWIRE WAS DIFFICULT TO REMOVE FROM THE MAMBA. THE PHYSICIAN REMOVED BOTH THE MAMBA CATHETER AND ROTAWIRE TOGETHER. THEN, THE ROTAWIRE REMOVED FROM THE MAMBA OUTSIDE THE PATIENT, AND TRIED TO FLUSH THE MAMBA BUT COULD NOT FLUSH IT. THE MAMBA CATHETER WAS ABLE TO FLUSH IT WITH A NON-BOSTON SCIENTIFIC SYRINGE. THERE WERE NO PATIENT COMPLICATIONS REPORTED
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18852286 ↗MalfunctionJun 20, 2023Difficult to Remove; Difficult to Advance; Difficult to Remove; Difficult to Advance
IT WAS REPORTED THAT DIFFICULTY TO REMOVE A MICROCATHETER OCCURRED. THE 100% STENOSED LESION WAS LOCATED IN A MILDLY TO MODERATELY TORTUOUS AND MODERATELY TO SEVERELY CALCIFIED RIGHT CORONARY ARTERY. THIS 150CM MAMBA FLEX MICROCATHETER WAS SELECTED FOR USE. UPON ADVANCEMENT OF MAMBA TOWARDS OVER A NON-BOSTON SCIENTIFIC GUIDEWIRE TO THE MID AND PROXIMAL CHRONIC TOTAL OCCLUSION (CTO) LESION, THE GUIDEWIRE KNUCKLED BACK ONTO ITSELF, AND THE PHYSICIAN WAS ABLE TO STRAIGHTEN GUIDEWIRE. THE PHYSICIAN TRIED TO ADVANCE THE GUIDEWIRE AND MAMBA TOGETHER, BUT THE GUIDEWIRE BECAME FROZEN IN THE MAMBA CATHETER AND WAS UNABLE TO ADVANCE AND REMOVED FROM MAMBA CATHETER. MULTIPLE ATTEMPTS WERE MADE TO REMOVE THE GUIDEWIRE BUT WERE UNSUCCESSFUL. THEN, BOTH THE GUIDEWIRE AND MICROCATHETER HAD TO BE PULLED AND REMOVED TOGETHER AS A UNIT. THE PROCEDURE WAS CANCELED AND THERE WERE NO PATIENT COMPLICATIONS RESULTED IN RELATION TO THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17161475 ↗MalfunctionAug 23, 2022Difficult to Flush; Physical Resistance/Sticking; Difficult to Flush; Physical Resistance/Sticking
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON (B)(6) 2022 IT WAS REPORTED THAT A GUIDEWIRE COULD NOT ADVANCE THROUGH THE DEVICE. A MAMBA INFUSION CATHETER WAS SELECTED FOR USE. DURING PREPARATION A GUIDEWIRE FAILED TO LOAD THROUGH THE MAMBA. THE MAMBA WAS REPLACED WITH ANOTHER MAMBA AND THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, DEVICE ANALYSIS REVEALED FOREIGN MATERIAL WITHIN THE MAMBA.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15279041 ↗InjuryMay 11, 2022Difficult to Remove; Adverse Event Without Identified Device or Use Problem; Difficult to Remove; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DIFFICULTY TO REMOVE A MICROCATHETER OCCURRED. A PERCUTANEOUS CORONARY INTERVENTION (PCI) OF A CHRONIC TOTAL OCCLUDED ARTERY WAS PERFORMED ON A PATIENT WITH CORONARY ARTERY DISEASE (CAD). THE TARGET LESION WAS LOCATED IN THE 100% STENOSED SEVERELY CALCIFIED BIFURCATED LEFT MAIN (LM) ARTERY AND BIFURCATED OBTUSE MARGIN (OM) ARTERY. A 150 CM MAMBA FLEX MICROCATHETER WAS ADVANCED TO THE CALCIFIED LESION, DISTAL TO THE CHRONIC TOTAL OCCLUSION (CTO), BUT DIFFICULTIES REMOVING THE DEVICE OCCURRED. THE DEVICE WAS UNABLE TO PULL BACK. ANOTHER WIRE AND BALLOON WERE INSERTED BESIDE THE MICROCATHETER, AND THE BALLOON WAS INFLATED SEVERAL TIMES. THE MAMBA THEN BECAME UNSTUCK, AND WAS REMOVED INTACT. THE PROCEDURE WAS COMPLETED WITH OTHER STENTS, WHICH WERE POST DILATED. THERE WERE NO FURTHER ISSUES, AND NO PATIENT COMPLICATIONS RESULTED IN RELATION TO THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14360667 ↗MalfunctionMar 20, 2022Difficult to Remove; Device-Device Incompatibility; Physical Resistance/Sticking; Difficult to Remove; Device-Device Incompatibility; Physical Resistance/Sticking
IT REPORTED THAT REMOVAL DIFFICULTIES OCCURRED. A PERCUTANEOUS CORONARY INTERVENTION WAS BEING PERFORMED. THE TARGET LESION WAS LOCATED IN THE 99% STENOSED SEVERELY CALCIFIED AND MILDLY TORTUOUS LEFT ANTERIOR DESCENDING ARTERY. THIS 135CM MAMBA FLEX MICROCATHETER ALONG WITH A ROTAWIRE GUIDEWIRE WERE SELECTED. DURING THE PROCEDURE THE MAMBA MICROCATHETER BECAME STICKY AND WAS VERY DIFFICULT TO REMOVE FROM THE ROTAWIRE. THEY ATTEMPTED TO FLUSH THE LUMEN WHICH WAS ALSO DIFFICULT, THEY REMOVE THE DEVICE FROM THE PATIENT BY FIRMLY PULLING THE MAMBA OFF OF THE ROTAWIRE. DURING THE REMOVAL THE ROTAWIRE GUIDEWIRE BECAME SEVERELY MANGLED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13830516 ↗MalfunctionMar 5, 2021Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED A SEPARATION HAD OCCURRED. WHILE A PROCEDURE WAS IN PROGRESS, THE TIP OF THE 135CM MAMBA FLEX CATHETER SEPARATED FROM THE REST OF THE DEVICE. ALL COMPONENTS OF THE DEVICE REMAINED ON THE WIRE, AND THE PHYSICIAN WAS ABLE TO REMOVE EVERYTHING FROM THE PATIENT ANATOMY. IT WAS NOTED THAT THE VESSEL WAS SEVERELY CALCIFIED AND THOUGHT TO HAVE CAUSED THE ISSUE.
Patient problems: Insufficient Information
MAUDE report 11419052 ↗MalfunctionFeb 3, 2021Entrapment of Device; Difficult to Remove; Entrapment of Device; Difficult to Remove
IT WAS REPORTED THE CATHETER WAS DIFFICULT TO REMOVE AND FROZE ON THE GUIDEWIRE. AN ATHERECTOMY PROCEDURE WAS BEING PERFORMED ON A 90% STENOSED, SEVERELY CALCIFIED AND MILDLY TORTUOUS LESION IN THE MID LEFT ANTERIOR DESCENDING CORONARY ARTERY. A MAMBA FLEX MICROCATHETER WAS BEING ADVANCED OVER A NON-BOSTON SCIENTIFIC GUIDEWIRE AND COULD NOT BE ADVANCED ANY FURTHER OR BE REMOVED. IT BECAME STUCK ON THE GUIDEWIRE AND BOTH THE GUIDEWIRE AND MICROCATHETER HAD TO BE REMOVED TOGETHER AS A UNIT. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH A DIFFERENT DEVICE WITHOUT ISSUE OR PATIENT INJURY. THE PATIENT WAS STABLE POST PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11272179 ↗MalfunctionNov 2, 2020Device Contamination with Chemical or Other Material; Physical Resistance/Sticking; Device Contamination with Chemical or Other Material; Physical Resistance/Sticking
IT WAS REPORTED THAT FOREIGN MATERIAL WAS PRESENT IN THE DEVICE. A PERCUTANEOUS CORONARY INTERVENTION WAS BEING PERFORMED TO TREAT A BLOCKAGE IN THE OSTIAL RIGHT CORONARY ARTERY. A ROTA WIRE WAS BEING USED AND WOULD NOT ADVANCE THROUGH THE MAMBA FLEX MICROCATHETER. THE CATHETER WAS REMOVED AND FLUSHED AND A HAIR-LIKE SUBSTANCE CAME OUT. THE MAMBA DEVICE WAS NOT REINSERTED IN THE BODY. THE ROTA WIRE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10771583 ↗
Other Boston Scientific Corporation products
- INGEVITY MRI7 models · 16,601 reports
- INGEVITY+3 models · 16,054 reports
- EMBLEM S-ICD4 models · 13,295 reports · 1 recall
- WATCHMAN25 models · 8,024 reports · 6 recalls
- AMS 800 Artificial Urinary Sphincter31 models · 7,515 reports · 2 recalls
- ENDOTAK RELIANCE SG9 models · 6,540 reports · 2 recalls
- RELIANCE 4-FRONT11 models · 5,739 reports
- FINELINE II EZ Sterox6 models · 5,633 reports
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page